Bill · H.R. 6626· House(119-HR-6626)
PFAS Accountability Act of 2025
- Introduced
- 12/11/2025
- Last activity
- 12/11/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Madeleine Dean
- Cosponsors
- - 4 - 0
- Introduced
- In Committee
What this bill would do
The PFAS Accountability Act of 2025 aims to amend the Toxic Substances Control Act. It seeks to create a Federal cause of action for people significantly exposed to per- and polyfluoroalkyl substances, known as PFAS. The bill establishes a medical monitoring remedy to help address harm caused by exposure. It intends to encourage research into the safety of these substances and increase accountability for irresponsible manufacturing or use. Additionally, the Act aims to shift medical monitoring costs from individuals to the parties responsible for the exposure.
Yes· 3 of 9
Does this give people more protection from unfair business practices?+7
The bill creates a federal cause of action to hold manufacturers accountable for PFAS exposure.
Does this make health care easier to get in general?+6
The bill provides for medical monitoring to detect diseases associated with PFAS exposure.
Does this better protect air, water and wildlife?+6
The bill increases accountability for the irresponsible discharge of PFAS into the environment.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Access to Legal Recourse: The bill establishes a Federal cause of action that allows individuals significantly exposed to PFAS, or those with reasonable grounds to suspect such exposure, to bring claims in district court (Section 4, subsection b).
-
Medical Monitoring Relief: The bill provides a remedy where a court may award medical monitoring to individuals or classes who have suffered an increased risk of disease due to PFAS exposure (Section 4, subsection c, paragraph 1).
-
Financial Relief for Health Costs: The Act aims to shift the costs of medical monitoring away from the individuals and onto the parties responsible for the exposure (Section 3, paragraph 2, subclause B).
-
Simplified Proof of Exposure: The bill creates a presumption of significant exposure if an individual demonstrates that a defendant's manufacturing process released PFAS into an area where the individual was exposed for at least one year (Section 4, subsection c, paragraph 2, subclause A, i).
-
Increased Scientific Data: To address gaps in toxicological data, courts may order new or additional epidemiological or toxicological studies to better understand the health risks of PFAS (Section 4, subsection c, paragraph 4, subclause B).
Potential Negative Impacts for People
-
Burden of Proof regarding Risk: For medical monitoring to be awarded, an individual or class must demonstrate that their exposure resulted in an increased risk of developing a disease associated with PFAS exposure (Section 4, subsection c, paragraph 1, subclause B).
-
Potential for Rebuttal of Exposure Claims: Defendants have the ability to rebut the presumption of significant exposure by providing testing results from an independent provider that suggest the PFAS or metabolites were not present in sufficient quantities (Section 4, subsection c, paragraph 3, subclause A).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Healthcare Access+6Increases Research Funding+5
- Demographic And Interest Groups
- Good For Low Income Households+5Good For Urban Residents+4
- Economy And Finance
- Improves Consumer Protection+7
- Environment Energy And Infrastructure
- Improves Environmental Protections+6
- Education And Technology
- Increases Scientific Research Funding+5
- Governance And Ideology
- Improves Due Process+4
- Social Issues And Justice
- Improves Poverty Reduction+3
- 1/30/2026
- 1 Cosponsor added.
- 12/11/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 3 Cosponsors added.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Debbie DingellDemocrat · Michigan
Dwight EvansDemocrat · Pennsylvania
Jerrold NadlerDemocrat · New York
Rashida TlaibDemocrat · Michigan